Poland· PL-100433799

Lakcid ENTERO

A saccharomyces boulardii product containing saccharomyces cerevisiae var. boulardii, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC A07FA02

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedLakcid ENTEROATCA07FA02REGISTER NO.PL-100433799PACKS LISTED4CHECKEDSeptember 27, 2026

Where it is registered

Saccharomyces boulardii is registered in 10 of 19 countries.

Countries holding a registration under ATC A07FA02 (saccharomyces boulardii), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose

Saccharomyces boulardii · ATC A07FA02

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of saccharomyces boulardii costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Saccharomyces boulardii · price per daily dose (1 g)

USD · FX 28 Sept 2026

  • CH Switzerland$4.16
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Saccharomyces cerevisiae var. boulardii
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
A07FA02
ATC class
Saccharomyces boulardii
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 4

  • gtin
    05909991462796
  • gtin
    05909991462789
  • gtin
    05909991462765
  • gtin
    05909991462772

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Saccharomyces boulardii in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All saccharomyces boulardii products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Yomogi
  • Belgium · Sacchiflora
  • Cyprus · Bioflor
  • Germany · Boulardii Pz Entsprechend Mindestens 10^10 Lebensfähige Zellen/G, Lyophilisiert, Ceritract
  • Italy · Codex, Preparazione H
  • Portugal · Prolif
  • Sweden · Precosa
  • Slovakia · Yomogi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/052d016d-0ed6-4857-a8e4-112db93c3280
GET /v1/drugs/052d016d-0ed6-4857-a8e4-112db93c3280?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "250 mg",
  "packaging": "05909991462796 ¦ OTC ¦ 140552\n10 kaps.\n05909991462789 ¦ OTC ¦ 140553\n20 kaps.\n05909991462765 ¦ OTC ¦ 140554\n50 kaps.\n05909991462772 ¦ OTC ¦ 140555\n100 kaps.",
  "substance": "Saccharomyces cerevisiae var. boulardii 250 mg",
  "common_name": "Saccharomyces cerevisiae var. boulardii",
  "pl_product_id": "100433799",
  "pozwolenie_nr": "26594",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about saccharomyces boulardii.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.